Kanagawa, Japan

Sachiko Yoshimura

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 46(Granted Patents)


Location History:

  • Kawasaki, JP (2014)
  • Kanagawa, JP (2013 - 2022)
  • Tokyo, JP (2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):

Title: Innovations in Cancer Treatment: The Contributions of Sachiko Yoshimura

Introduction

Sachiko Yoshimura, based in Kanagawa, Japan, is a distinguished inventor recognized for her significant contributions to the field of cancer research. With a remarkable 32 patents to her name, her innovative approaches are paving the way for advanced therapeutic techniques aimed at improving cancer treatment outcomes.

Latest Patents

Among her notable inventions, Yoshimura's latest patents include the engineering of lymphocytes with specific alpha and beta chains on their T-cell receptor. These inventions detail methods to identify TCR-recognizing cancer-specific antigens, highlighting the creation of TCR-engineered T cells that possess antigen-specific cytotoxic activity. Furthermore, her patents provide insights into methods for treating cancer by administering these engineered T lymphocytes, along with the development of antibodies produced via these methods. Additionally, her work on UBE2T peptides and related vaccines presents a promising avenue for peptide vaccines against cancer, focusing on inducing cytotoxic T lymphocytes (CTL) and anti-tumor immunity through epitope peptides derived from UBE2T.

Career Highlights

Throughout her career, Yoshimura has made strides in her field through her roles in significant companies. She has worked at Oncotherapy Science, Incorporated and the University of Chicago, where her research has influenced cancer therapy strategies and contributed to advancing the understanding of immune responses to tumors.

Collaborations

In her journey as an inventor, Yoshimura has collaborated with prominent colleagues, including Takuya Tsunoda and Tomohisa Watanabe. These collaborations have not only enriched her research but have also emphasized the importance of teamwork in tackling the complex challenges presented by cancer.

Conclusion

Sachiko Yoshimura's innovations in cancer treatment, as evidenced by her extensive patent portfolio, reflect her commitment to enhancing therapeutic methodologies. Her work continues to inspire future research and development in the fight against cancer, showcasing the critical role inventors play in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…